High-dose intravenous immunoglobulin delays clearance of von Willebrand factor in acquired von Willebrand disease

Thromb Haemost. 1995 May;73(5):891-2.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Autoantibodies / immunology
  • Autoimmune Diseases / metabolism*
  • Autoimmune Diseases / therapy
  • Female
  • Hematoma / etiology
  • Humans
  • Immunoglobulin G / immunology
  • Immunoglobulins, Intravenous / pharmacology*
  • Immunoglobulins, Intravenous / therapeutic use
  • Metabolic Clearance Rate
  • von Willebrand Diseases / metabolism*
  • von Willebrand Diseases / therapy
  • von Willebrand Factor / metabolism
  • von Willebrand Factor / pharmacokinetics*

Substances

  • Autoantibodies
  • Immunoglobulin G
  • Immunoglobulins, Intravenous
  • von Willebrand Factor